The ability of viable keratinocytes to release IL-36γ in both a soluble and an EV-encapsulated manner would suggest that it should be released by papilloma cells since they contain high intracellular levels, thus activating an inflammatory response in the larynx of RRP patients. This evidence concerns the gene IL36G and papilloma.